Cizzle

CIZ.L

Tags: GB Healthcare Biotechnology

Cizzle Biotechnology Holdings Plc Price (CIZ.L)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

355,861,000

(22.1547)%

Market Cap of Cizzle (CIZ.L)

Market cap:

As of , CIZ.L has a market cap of . This makes CIZ.L the 1123th most valuable company in the GB by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $1.4-2.8
Market Cap 6.34M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Dr. Allan John Syms
IPO Date: May, 14, 2021
Country: GB
Currency: GBp
Headquaters: No Data
Employees: 4

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: